<VariationArchive VariationID="375624" VariationName="NM_001197104.2(KMT2A):c.6002_6005del (p.Phe2001fs)" VariationType="Deletion" Accession="VCV000375624" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2017-02-17" MostRecentSubmission="2017-02-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="362438" VariationID="375624">
      <GeneList>
        <Gene Symbol="KMT2A" FullName="lysine methyltransferase 2A" GeneID="4297" HGNC_ID="HGNC:7132" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="118436492" stop="118526832" display_start="118436492" display_stop="118526832" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118307204" stop="118397538" display_start="118307204" display_stop="118397538" Strand="+" />
          </Location>
          <OMIM>159555</OMIM>
          <Haploinsufficiency last_evaluated="2018-05-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-05-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001197104.2(KMT2A):c.6002_6005del (p.Phe2001fs)</Name>
      <CanonicalSPDI>NC_000011.10:118499339:TGTTTGT:TGT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="118499340" stop="118499343" display_start="118499340" display_stop="118499343" variantLength="4" positionVCF="118499339" referenceAlleleVCF="GTGTT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118370055" stop="118370058" display_start="118370055" display_stop="118370058" variantLength="4" positionVCF="118370054" referenceAlleleVCF="GTGTT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>F2001fs</ProteinChange>
      <ProteinChange>F1998fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.118499343_118499346del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.118499343_118499346del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.118370058_118370061del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.118370058_118370061del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_027813.1" sequenceAccession="NG_027813" sequenceVersion="1" change="g.67854_67857del">
            <Expression>NG_027813.1:g.67854_67857del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001197104.2" sequenceAccession="NM_001197104" sequenceVersion="2" change="c.6002_6005del" MANESelect="true">
            <Expression>NM_001197104.2:c.6002_6005del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001184033.1" sequenceAccession="NP_001184033" sequenceVersion="1" change="p.Phe2001fs">
            <Expression>NP_001184033.1:p.Phe2001fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005933.4" sequenceAccession="NM_005933" sequenceVersion="4" change="c.5993_5996del">
            <Expression>NM_005933.4:c.5993_5996del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005924.2" sequenceAccession="NP_005924" sequenceVersion="2" change="p.Phe1998fs">
            <Expression>NP_005924.2:p.Phe1998fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_613" sequenceAccession="LRG_613">
            <Expression>LRG_613:g.67854_67857del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_613t1" sequenceAccession="LRG_613t1">
            <Expression>LRG_613t1:c.6002_6005del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_613p1" sequenceAccession="LRG_613p1" change="p.Phe2001fs">
            <Expression>LRG_613p1:p.Phe2001fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16044392" DB="ClinGen" />
        <XRef Type="rs" ID="1057519408" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="termination codon change">
        <XRef ID="0309" DB="Variation Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001197104.2(KMT2A):c.6002_6005del (p.Phe2001fs) AND Wiedemann-Steiner syndrome" Accession="RCV000417101" Version="2">
        <ClassifiedConditionList TraitSetID="8851">
          <ClassifiedCondition DB="MedGen" ID="C1854630">Wiedemann-Steiner syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-02-17" MostRecentSubmission="2017-02-17">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="8851" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5217" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Growth deficiency and mental retardation with facial dysmorphism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Wiedemann-Steiner syndrome</ElementValue>
                <XRef ID="MONDO:0011518" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">WDSTS</ElementValue>
                <XRef Type="MIM" ID="605130" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5565" />
                <XRef ID="5565" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Wiedemann-Steiner syndrome (WSS) is characterized by developmental delay, intellectual disability, and characteristic facial features, with or without additional congenital anomalies. The facial features include thick eyebrows with lateral flare, vertically narrow and downslanted palpebral fissures, widely spaced eyes, long eyelashes, wide nasal bridge, broad nasal tip, thin vermilion of the upper lip, and thick scalp hair. About 60% of affected individuals have hypertrichosis cubiti ("hairy elbows"), which was once thought to be pathognomic for the syndrome, with a majority having hypertrichosis of other body parts. Other clinical features include feeding difficulties, prenatal and postnatal growth restriction, epilepsy, ophthalmologic anomalies, congenital heart defects, hand anomalies (such as brachydactyly and clinodactyly), hypotonia, vertebral anomalies (especially fusion anomalies of the cervical spine), renal and uterine anomalies, immune dysfunction, brain malformations, and dental anomalies.</Attribute>
                <XRef ID="NBK580718" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">35617449</ID>
                <ID Source="BookShelf">NBK580718</ID>
              </Citation>
              <XRef ID="319182" DB="Orphanet" />
              <XRef ID="C1854630" DB="MedGen" />
              <XRef ID="MONDO:0011518" DB="MONDO" />
              <XRef Type="MIM" ID="605130" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="967817" SubmissionDate="2017-02-15" DateLastUpdated="2017-02-17" DateCreated="2017-02-17">
        <ClinVarSubmissionID localKey="SUB2188335" submittedAssembly="GRCh37" title="SUB2188335" />
        <ClinVarAccession Accession="SCV000485026" DateUpdated="2017-02-17" DateCreated="2017-02-17" Type="SCV" Version="1" SubmitterName="Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille" OrgID="505759" OrganizationCategory="laboratory" OrgAbbreviation="CHRUL" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <TypePlatform>Next-generation sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="Human Phenotype Ontology" ID="HP:0001249" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KMT2A">
              <Name>lysine methyltransferase 2A</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_001197104.1:exon 23</GeneLocation>
          </Location>
          <FunctionalConsequence Value="termination codon change">
            <XRef DB="Variation Ontology" ID="0309" URL="http://purl.obolibrary.org/obo/VariO_0309" />
          </FunctionalConsequence>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001197104.1:c.6002_6005del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605130" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2188335</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="967817" TraitType="Disease" MappingType="XRef" MappingValue="605130" MappingRef="OMIM">
        <MedGen CUI="C1854630" Name="Wiedemann-Steiner syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="967817" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001249" MappingRef="Human Phenotype Ontology">
        <MedGen CUI="C3714756" Name="Intellectual disability" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

